Concepedia

Isett Laux

IL

12

Publications

825

Citations

11

H-Index

2000

Active since

Affiliations

University of California, Los Angeles(Current)

Cedars-Sinai Medical Center

Comprehensive Blood & Cancer Center

UPMC Hillman Cancer Center

St. Jude Medical Center

Isett Laux is an author at University of California, Los Angeles specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2000–2015

12

Publications

12

The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes

Ali Khoshnan, Charles Tindell, Isett Laux et al. · The Journal of Immunology · 2000 · 218 citations

, , +17

The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation

Ndaisha Slaughter, Isett Laux, Xiaolin Tu et al. · Clinical Immunology · 2003 · 90 citations

, , +12

Epithelial membrane protein-1 is a biomarker of gefitinib resistance

Anjali Jain, Charles Tindell, Isett Laux et al. · Proceedings of the National Academy of Sciences · 2005 · 88 citations · Full text

, , +16

Response Differences between Human CD4+ and CD8+ T-Cells during CD28 Costimulation: Implications for Immune Cell-Based Therapies and Studies Related to the Expansion of Double-Positive T-Cells during Aging

Isett Laux, Ali Khoshnan, Charles Tindell et al. · Clinical Immunology · 2000 · 85 citations

, , +10

Phase 1 dose‐escalation trial evaluating the combination of the selective MET (mesenchymal‐epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib

Jonathan W. Goldman, Isett Laux, Ronald E. Savage et al. · Cancer · 2012 · 76 citations · Full text

Rows per page

1–5 of 12